Molecular effects of genistein, as a potential anticancer agent, on CXCR-4 and VEGF pathway in acute lymphoblastic leukemia

被引:0
|
作者
Mohsen Shahmoradi
Fatemeh Banisharif-Dehkordi
Mahnoush kouhihabibidehkordi
Mahdi GhatrehSamani
Mohammad-Saied Jami
Hedayatollah Shirzad
Batoul Pourgheysari
机构
[1] Shahrekord University of Medical Sciences,Cellular and Molecular Research Center, Basic Health Sciences Institute
[2] University of California Los Angeles (UCLA),Department of Neurology, David Geffen School of Medicine
[3] Shahrekord University of Medical Sciences,Medical Plants Research Center, Basic Health Sciences Institute
来源
Molecular Biology Reports | 2022年 / 49卷
关键词
Acute lymphoblastic leukemia; CXCR-4; Genistein; VEGF;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4161 / 4170
页数:9
相关论文
共 50 条
  • [31] The chemokine receptor CXCR-4 is preferentially expressed and functionally active in acute myeloid leukemia (AML) with myelomonocytic differentiation (FAB M4/5).
    Möhle, R
    Schittenhelm, M
    Failenschmid, C
    Bautz, F
    Kratz-Albers, K
    Serve, H
    Brugger, W
    Kanz, L
    BLOOD, 1998, 92 (10) : 602A - 603A
  • [32] Combined CXCR-4 Inhibition with Novel Agent GPC-100 (burixafor) and Beta 2 Adrenergic Receptor Blockade Enhances Cytarabine Response for Acute Myeloid Leukemia Blasts on Stroma
    Tang, Yueming
    Braun, Adam
    von Behren, Zachary
    Wu, Jieya
    Haley, Caitlyn
    Zhang, Chunxiao
    Loera, Brenda
    Cardarelli, Pina M.
    Caculitan, Nina
    Chien, Sylvia
    Dai, Jin
    Oehler, Vivian G.
    Zhang, Jianying
    Marcucci, Guido
    Becker, Pamela S.
    BLOOD, 2024, 144 : 2758 - 2759
  • [33] HMGA2 As a Potential Molecular Target in MLL-AF4 Positive Infant Acute Lymphoblastic Leukemia
    Eguchi-Ishimae, Minenori
    Eguchi, Mariko
    Wu, Zhouying
    Ming, Wen
    Iwabuki, Hidehiko
    Inukai, Takeshi
    Sugita, Kanji
    Ishii, Eiichi
    BLOOD, 2014, 124 (21)
  • [34] Notch3 sustains CXCR4 expression in acute T cell lymphoblastic leukemia progression
    Ferrandino, F.
    Bernardini, G.
    Grazioli, P.
    Campese, A. F.
    Bellavia, D.
    Checquolo, S.
    Screpanti, I.
    Felli, M. P.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S87 - S87
  • [35] CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment
    Juarez, J.
    Dela Pena, A.
    Baraz, R.
    Hewson, J.
    Khoo, M.
    Cisterne, A.
    Fricker, S.
    Fujii, N.
    Bradstock, K. F.
    Bendall, L. J.
    LEUKEMIA, 2007, 21 (06) : 1249 - 1257
  • [36] CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment
    J Juarez
    A Dela Pena
    R Baraz
    J Hewson
    M Khoo
    A Cisterne
    S Fricker
    N Fujii
    K F Bradstock
    L J Bendall
    Leukemia, 2007, 21 : 1249 - 1257
  • [37] EFFECTS OF AMSACRINE IN COMBINATION WITH OTHER ANTICANCER AGENTS IN HUMAN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS IN CULTURE
    KANO, Y
    SAKAMOTO, S
    KASAHARA, T
    AKUTSU, M
    INOUE, Y
    MIURA, Y
    LEUKEMIA RESEARCH, 1991, 15 (11) : 1059 - 1066
  • [38] High CXCR4 and low VLA-4 expression predicts poor survival in adults with acute lymphoblastic leukemia
    Ko, Sun-Young
    Park, Chan-Jeoung
    Park, Sang-Hyuk
    Cho, Young-Uk
    Jang, Seongsoo
    Seo, Eul-ju
    Kim, Nayoung
    Kim, Dae-Young
    Koh, Kyung Nam
    Im, Ho Joon
    Seo, Jong-Jin
    Chi, Hyun-Sook
    LEUKEMIA RESEARCH, 2014, 38 (01) : 65 - 70
  • [39] Microbial L-asparaginase as a Potential Therapeutic Agent for the Treatment of Acute Lymphoblastic Leukemia: The Pros and Cons
    El-Naggar, Noura El-Ahmady
    El-Ewasy, Sara M.
    El-Shweihy, Nancy M.
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2014, 10 (04) : 182 - 199
  • [40] Leukemogenic Pathway of MLL-AF4 Fusion-Positive Acute Lymphoblastic Leukemia
    Eguchi, Mariko
    Eguchi-Ishimae, Minenori
    Ishii, Eiichi
    BLOOD, 2017, 130